E-LIB Suche - Ergebnisse für: Reynolds, Kerry

1

Immune-related adverse events requiring hospitalization in ..:

Falade, Ayo ; Zubiri, Leyre ; Wu, Chia-Yun...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

2

386 SINGLE CELL DISSECTION OF CHECKPOINT INHIBITOR AND AUTO..:

Thomas, Molly ; Chan, Thomas ; Smith, Neal...
Gastroenterology. 166 (2024) 5 - p. S-86 , 2024

Link: https://doi.org/10.1016/..

3

Cancer type and histology influence cutaneous immunotherapy..:

Wan, Guihong ; Khattab, Sara ; Leung, Bonnie W...
British Journal of Dermatology. 191 (2024) 1 - p. 117-124 , 2024

Link: https://doi.org/10.1093/..

4

Multi-organ immune-related adverse events from immune check..:

Wan, Guihong ; Chen, Wenxin ; Khattab, Sara...
The Lancet Oncology. 25 (2024) 8 - p. 1053-1069 , 2024

Link: https://doi.org/10.1016/..

5

Pilot Trial of an Educational Immunotherapy Intervention fo..:

Petrillo, Laura ; Hsu, Kelly E. ; Pintro, Kedie...
Journal of Pain and Symptom Management. 67 (2024) 5 - p. e575 , 2024

Link: https://doi.org/10.1016/..

6

Pre-existing inflammatory disease predicts cutaneous immuno..:

Wan, Guihong ; Nguyen, Nga ; Leung, Bonnie W....
Journal of the American Academy of Dermatology. 90 (2024) 2 - p. 418-420 , 2024

Link: https://doi.org/10.1016/..

7

Derivation and external validation of a simple risk score f..:

Gupta, Shruti ; Glezerman, Ilya G ; Hirsch, Jamie S...
BMJ. , 2024

Link: https://doi.org/10.1136/..

8

Tofacitinib is Effective in Treating Refractory Immune Chec..:

Wang, Mike ; Reynolds, Kerry L. ; Montazeri, Kamaneh...
Clinical Gastroenterology and Hepatology. 22 (2024) 7 - p. 1539-1541.e2 , 2024

Link: https://doi.org/10.1016/..

9

Associations between dermatologic immune-related adverse ev..:

Reardon, Rachel M. ; Perlman, Katherine L. ; Asdourian, Maria S....
Journal of the American Academy of Dermatology. , 2024

Link: https://doi.org/10.1016/..

10

A Rare Presentation of Aggressive Renal Cell Carcinoma and ..:

McLoughlin, Daniel E ; Chevalier, Nicholas ; Choy, Edwin...
The Oncologist. 28 (2023) 12 - p. 1094-1099 , 2023

Link: https://doi.org/10.1093/..

11

Development of multiple cutaneous immune-related adverse ev..:

Asdourian, Maria S. ; Shah, Nishi ; Jacoby, Ted V....
Journal of the American Academy of Dermatology. 88 (2023) 2 - p. 485-487 , 2023

Link: https://doi.org/10.1016/..

12

Evaluating patterns of co-occurrence between cutaneous and ..:

Asdourian, Maria S. ; Shah, Nishi ; Jacoby, Ted V....
Journal of the American Academy of Dermatology. 88 (2023) 1 - p. 246-249 , 2023

Link: https://doi.org/10.1016/..

13

Low-grade cutaneous immune-related adverse events leading t..:

Jacoby, Ted V. ; Asdourian, Maria S. ; Shah, Nishi...
Clinical and Experimental Dermatology. 48 (2023) 9 - p. 1058-1060 , 2023

Link: https://doi.org/10.1093/..

14

Morphologic characteristics of cutaneous immune-related adv..:

Asdourian, Maria S. ; Jacoby, Ted V. ; Shah, Nishi...
Journal of the American Academy of Dermatology. 88 (2023) 2 - p. 474-476 , 2023

Link: https://doi.org/10.1016/..

15

Noncutaneous immune-related adverse events predict overall ..:

Asdourian, Maria S. ; Jacoby, Ted V. ; Shah, Nishi...
Journal of the American Academy of Dermatology. 88 (2023) 6 - p. 1368-1370 , 2023

Link: https://doi.org/10.1016/..